Form 4: AbbVie Director Melody B. Meyer Reports Acquisition and Disposal of Shares

Director Melody B. Meyer reports acquiring restricted stock units and disposing of common stock in AbbVie Inc.

Summary

• On May 3, 2024, Melody B. Meyer, a director of AbbVie Inc., reported transactions involving AbbVie's common stock.
• Meyer acquired 1,322 restricted stock units (RSUs) under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These RSUs will be paid out in shares of AbbVie common stock upon separation from service, death, or a change in control.
• Meyer also disposed of 15,295 shares of common stock.
• Following these transactions, Meyer beneficially owns 15,295 shares of AbbVie common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting transactions. There's no inherent positive or negative implication.

Future Outlook

The RSUs will be paid out in shares of AbbVie common stock on the earlier of the director's separation from service, death, or the occurrence of a change in control (as defined in the Program).

Industry Context

This filing is a routine disclosure of insider transactions, which are common for directors and officers of publicly traded companies. These filings are monitored by investors for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions could have a minor impact on shareholders, as insider transactions are often scrutinized for signals about the company's prospects.

Key Dates